Who are the top medical devices investors & vc firms in new york?

Top medical devices investors & vc firms in new york include OrbiMed, Deerfield Management Company, Lerer Hippeau, Catalio Capital Management, LP, WCAS, Colle Capital Partners, Aisling Capital, Casdin Capital — 94 firms in total meet the criteria.

Fund	HQ	Invests	Stage	Check	CRM
OrbiMed 131 people · Leads rounds	New York	US	Pre-Seed–Late Stage	$1M – $75M	+ Add to CRM
Deerfield Management Company 90 people	New York	US	Growth–Late Stage	—	+ Add to CRM
Lerer Hippeau 24 people · Leads rounds	New York	US	Seed–Series B	$500K – $2M	+ Add to CRM
Catalio Capital Management, LP 36 people · Follows rounds	New York	US	Seed–Late Stage	—	+ Add to CRM
WCAS 49 people	New York	US	Growth–Late Stage	—	+ Add to CRM
Colle Capital Partners 30 people · Leads rounds	New York	US	Pre-Seed–Series A	$500K – $2M	+ Add to CRM
Aisling Capital 18 people	New York	US	Seed–Series C	—	+ Add to CRM
Casdin Capital 39 people · Follows rounds	New York	US	Seed–Series C	—	+ Add to CRM
Everywhere Ventures 14 people · Follows rounds	New York	US	Pre-Seed–Seed	$250K	+ Add to CRM
NYU Innovation Venture Fund 33 people	New York	US	Pre-Seed–Series A	$100K – $500K	+ Add to CRM
Emles Venture Partners 14 people · Follows rounds	New York	US	Pre-Seed–Seed	—	+ Add to CRM
The Argentum Group 10 people	New York	US	Growth–Late Stage	—	+ Add to CRM
Digitalis Ventures 15 people · Leads rounds	New York	US	Seed–Late Stage	$100K – $10M	+ Add to CRM
Black Opal Ventures 28 people	New York	US	Seed–Late Stage	—	+ Add to CRM
Blackstone Life Sciences 30 people	New York	US	Series A–Late Stage	$20M – $60M	+ Add to CRM
Signet Healthcare Partners 13 people · Leads rounds	New York	US	Growth–Late Stage	$10M – $50M	+ Add to CRM
Windham Capital Partners 17 people · Leads rounds	New York	US	Series A–Growth	$1M – $5M	+ Add to CRM
Forepont Capital Partners 26 people · Leads rounds	New York	US	Pre-Seed–Late Stage	—	+ Add to CRM
Essex Woodlands Healthcare Partners 18 people · Leads rounds	New York	US	Growth–Late Stage	$20M – $80M	+ Add to CRM
Oberland Capital 20 people	New York	US	Growth–Late Stage	$50M – $300M	+ Add to CRM
Adjuvant Capital 19 people	New York	US	Series A–Late Stage	$10M – $25M	+ Add to CRM
Medical Excellence Capital 21 people · Follows rounds	New York	US	Pre-Seed–Series B	—	+ Add to CRM
Plum Alley Investments 15 people · Follows rounds	New York	US	Pre-Seed–Series A	$500K – $1.5M	+ Add to CRM
Owl Rock Capital 20 people · Leads rounds	New York	US	Growth–Late Stage	$20M – $250M	+ Add to CRM

Medical Devices Investors & VC Firms in New York

Frequently asked questions

Related lists